Harnessing the Reactivity of Sulfinate Salts With Cystine: An Umpolung Approach to Residue‐Specific Peptide Modification
Abstract
ABSTRACT The first use of sulfinate salts for the late‐stage modification of peptidic disulfide bonds is reported. While the majority of cysteine‐based peptide modifications rely on the nucleophilicity of the side chain thiol functionality, umpolung approaches—exploiting instead the electrophilicity of the cystine disulfide—are underexplored. Using structurally diverse sulfinate salts, we have optimized a mild, photochemical strategy for the generation and coupling of carbon‐centered radicals with both symmetrical and electronically‐distinct, unsymmetrical cystine disulfides using high‐throughput experimentation techniques. A library of modified peptides was accessible, as confirmed by qualitative and quantitative analytical data, providing valuable insights into the matched reactivity of specific radical/disulfide substrate pairings. The method was broadly compatible with a range of unprotected amino acids, including histidine, tryptophan, and tyrosine, and can be used for the functionalization of biologically relevant peptides, as exemplified by the selective, late‐stage modification of a semaglutide analogue and the preparation of high‐value macrocyclic peptides.
Article Details
Authors (8)
Joshua M. Hammond
Research School of Chemistry Australian National University Canberra Australia
Esteban Suárez‐Picado
Research School of Chemistry Australian National University Canberra Australia
Lena von Sydow
Hanna Bruss
Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
Laurent Knerr
Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
Magnus Johansson
Department of Cell & Molecular Biology, Uppsala University
Anaïs Noisier
Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
Lara R. Malins
Research School of Chemistry, Australian National University